{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T07:38:33Z","timestamp":1773387513842,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY07366"],"award-info":[{"award-number":["EY07366"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.ophtha.2006.07.013","type":"journal-article","created":{"date-parts":[[2007,2,2]],"date-time":"2007-02-02T17:24:27Z","timestamp":1170437067000},"page":"334-339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Intravitreal Triamcinolone Acetonide for the Treatment of Immune Recovery Uveitis Macular Edema"],"prefix":"10.1016","volume":"114","author":[{"given":"Victoria L.","family":"Morrison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Kozak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie D.","family":"LaBree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley P.","family":"Azen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozcan O.","family":"Kayicioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2006.07.013_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00006982-200002000-00007","article-title":"Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy","volume":"20","author":"Song","year":"2000","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2006.07.013_bib2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1126\/science.277.5322.112","article-title":"Positive effects of combined antiretroviral therapy on CD4 T cell homeostasis and function in advanced HIV disease","volume":"277","author":"Autran","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ophtha.2006.07.013_bib3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1086\/515591","article-title":"Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315","volume":"178","author":"Lederman","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2006.07.013_bib4","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1056\/NEJM199512073332204","article-title":"A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection","volume":"333","author":"Markowitz","year":"1995","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ophtha.2006.07.013_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archopht.116.2.169","article-title":"Immune recovery vitreitis associated with inactive cytomegalovirus retinitis","volume":"116","author":"Karavellas","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.07.013_bib6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1086\/314639","article-title":"Incidence of immune recovery vitreitis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy","volume":"179","author":"Karavellas","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2006.07.013_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0002-9394(00)00528-6","article-title":"Long-term posterior and anterior segment complications of immune recovery uveitis associated with cytomegalovirus retinitis","volume":"130","author":"Karavellas","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.07.013_bib8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00006982-199809000-00010","article-title":"Vitreomacular traction syndrome following highly active antiretroviral therapy in AIDS patients with cytomegalovirus retinitis","volume":"18","author":"Canzano","year":"1998","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2006.07.013_bib9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1001\/jama.283.5.653","article-title":"Cytomegalovirus retinitis in the era of highly active antiretroviral therapy","volume":"283","author":"Whitcup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2006.07.013_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0002-9394(00)00530-4","article-title":"Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy","volume":"130","author":"Robinson","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.07.013_bib11","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0002-9394(00)00356-1","article-title":"Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy","volume":"129","author":"Nguyen","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.07.013_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0002-9394(01)01322-8","article-title":"Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy","volume":"133","author":"Jabs","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.07.013_bib13","first-page":"9","article-title":"Immune recovery uveitis","author":"Dunn","year":"2001","journal-title":"Hopkins HIV Report"},{"key":"10.1016\/j.ophtha.2006.07.013_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1076\/ocii.7.3.215.4010","article-title":"Immune recovery uveitis","volume":"7","author":"Holland","year":"1999","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2006.07.013_bib15","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00006982-200406000-00007","article-title":"Long-term results of treatment of macular complications in eyes with immune recovery uveitis using a graded treatment approach","volume":"24","author":"El-Bradey","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2006.07.013_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-200102000-00001","article-title":"Immune recovery vitritis and uveitis in AIDS","volume":"21","author":"Karavellas","year":"2001","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2006.07.013_bib17","first-page":"636","article-title":"Valganciclovir therapy for immune recovery uveitis complicated by macular edema","volume":"137","author":"Kosobucki","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.07.013_bib18","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/bjo.83.5.540","article-title":"Treatment of immune recovery vitreitis with local steroids","volume":"83","author":"Henderson","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.07.013_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archopht.121.1.57","article-title":"Intravitreal injection of triamcinolone for diffuse diabetic macular edema","volume":"121","author":"Jonas","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.07.013_bib20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0002-9394(01)01010-8","article-title":"Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema","volume":"132","author":"Jonas","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.07.013_bib21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0002-9394(02)01938-4","article-title":"Intravitreal triamcinolone for refractory pseudophakic macular edema","volume":"135","author":"Benhamou","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.07.013_bib22","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0002-9394(03)00230-7","article-title":"Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema","volume":"136","author":"Jonas","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.07.013_bib23","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0161-6420(00)00658-8","article-title":"Intravitreal triamcinolone for uveitis cystoid macular edema: an optical coherence tomography study","volume":"108","author":"Antcliff","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2006.07.013_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/bjo.87.3.361","article-title":"Intravitreal injection of triamcinolone acetonide as treatment for chronic uveitis","volume":"87","author":"Degenring","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.07.013_bib25","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0002-9394(03)00228-9","article-title":"Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion","volume":"136","author":"Park","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.07.013_bib26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/bjo.86.2.247","article-title":"Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion","volume":"86","author":"Greenberg","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.07.013_bib27","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0002-9394(03)00266-6","article-title":"Intravitreal triamcinolone acetonide for idiopathic cystoid macular edema","volume":"136","author":"Scott","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.07.013_bib28","doi-asserted-by":"crossref","unstructured":"Kosobucki BR, Freeman WR, Cheng L. Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomized eye. Br J Ophthalmol 2006;90:705\u20138.","DOI":"10.1136\/bjo.2005.088278"},{"key":"10.1016\/j.ophtha.2006.07.013_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9394(14)71968-3","article-title":"Correlation between intraocular pressure and CD4+ T-lymphocyte counts in patients with human immunodeficiency virus with and without cytomegalovirus retinitis","volume":"122","author":"Arevalo","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.07.013_bib30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archopht.121.1.57","article-title":"Intravitreal injection of triamcinolone for diffuse diabetic macular edema","volume":"121","author":"Jonas","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.07.013_bib31","doi-asserted-by":"crossref","unstructured":"Morrison VL, Koh HJ, Cheng L, et al. Intravitreal toxicity of the Kenalog vehicle (benzyl alcohol) in rabbits. Retina 2006;26:339\u201344.","DOI":"10.1097\/00006982-200603000-00014"},{"key":"10.1016\/j.ophtha.2006.07.013_bib32","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00417-002-0547-y","article-title":"Repeated intravitreal injections of triamcinolone acetonide as treatment of progressive exudative age-related macular degeneration","volume":"240","author":"Jonas","year":"2002","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.07.013_bib33","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0002-9394(00)00882-5","article-title":"Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy","volume":"131","author":"Jonas","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.07.013_bib34","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/archopht.122.7.1085","article-title":"Intravitreal injection of triamcinolone for diffuse macular edema","volume":"122","author":"Rodriguez-Coleman","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.07.013_bib35","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1001\/archopht.122.7.1086","article-title":"Intravitreal injection of triamcinolone for diffuse macular edema","volume":"122","author":"Jonas","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.07.013_bib36","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1136\/bjo.2005.067744","article-title":"Comparison of different techniques for purification of triamcinolone acetonide suspension for intravitreal use","volume":"89","author":"Garcia-Arumi","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.07.013_bib37","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1080\/00365540260348644","article-title":"Reactivation of CMV retinitis after treatment with subtenon corticosteroids for immune recovery uveitis in a patient with AIDS","volume":"34","author":"Dalessandro","year":"2002","journal-title":"Scand J Infect Dis"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642006009870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642006009870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:50:26Z","timestamp":1758981026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642006009870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0161642006009870"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2006.07.013","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravitreal Triamcinolone Acetonide for the Treatment of Immune Recovery Uveitis Macular Edema","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2006.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}